Transforming Growth Factor-β

Principles of Bone Biology: Volume 1-2, Third Edition

Volumn , Issue , 2008, Pages 1145-1166

  Dallas, Sarah L ^a   Alliston, Tamara ^b   Bonewald, Lynda F ^c  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954641420     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373884-4.00067-7     Document Type: Chapter

References (225)

1. T. Alliston, L. Choy, P. Ducy, G. Karsenty and R. Derynck (2001) TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J. 20 2254-2272.
2. T. Alliston, E. Piek and R. Derynck (2008) The TGF-beta family in skeletal development and maintenance. R. Derynck, K. Miyazono (Eds) The TGF-beta Family Cold Spring Harbor Press 667-723.
3. J.P. Annes, J.S. Munger and D.B. Rifkin (2003) Making sense of latent TGFbeta activation. J. Cell Sci. 116 217-224.
4. J.P. Annes, Y. Chen, J.S. Munger and D.B. Rifkin (2004) Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J. Cell Biol. 165 723-734.
5. M.E. Antosz, C.G. Bellows and J.E. Aubin (1989) Effects of transforming growth factor beta and epidermal growth factor on cell proliferation and the formation of bone nodules in isolated fetal rat calvaria cells. J. Cell Physiol. 140 386-395.
6. E. Atti, S. Gomez, S.M. Wahl, R. Mendelsohn, E. Paschalis and A.L. Boskey (2002) Effects of transforming growth factor-beta deficiency on bone development: A Fourier transform-infrared imaging analysis. Bone 31 675-684.
7. L. Attisano, C. Silvestri, L. Izzi and E. Labbe (2001) The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling. Mol. Cell. Endocrinol. 180 3-11.
8. L. Attisano, J.L. Wrana, F. Lopez-Casillas and J. Massague (1994) TGF-beta receptors and actions. Biochim. Biophys. Acta, 1222 71-80.
9. M.O. Baffi, E. Slattery, P. Sohn, H.L. Moses, A. Chytil and R. Serra (2004) Conditional deletion of the TGF-beta type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones. Dev. Biol. 276 124-142.
10. M.O. Baffi, M.A. Moran and R. Serra (2006) Tgfbr2 regulates the maintenance of boundaries in the axial skeleton. Dev. Biol. 296 363-374.
11. G. Balooch, M. Balooch, R.K. Nalla, S. Schilling, E.H. Filvaroff, G.W. Marshall, S.J. Marshall, R.O. Ritchie, R. Derynck and T. Alliston (2005) TGF-beta regulates the mechanical properties and composition of bone matrix. Proc. Natl. Acad. Sci. USA, 102 18813-18818.
12. L.S. Beck, L. Deguzman, W.P. Lee, Y. Xu, L.A. McFatridge, N.A. Gillett and E.P. Amento (1991) Rapid publication. TGF-beta 1 induces bone closure of skull defects. J. Bone Miner. Res. 6 1257-1265.
13. E.N. Blaney Davidson, E.L. Vitters, W.B. van den Berg and P.M. van der Kraan (2006) TGF beta-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7. Arthritis Res. Ther. 8 R65.
14. L. Blavier, A. Lazaryev, J. Groffen, N. Heisterkamp, Y.A. DeClerck and V. Kaartinen (2001) TGF-beta3-induced palatogenesis requires matrix metalloproteinases. Mol. Biol. Cell, 12 1457-1466.
15. G.P. Boivin, B.A. O'Toole, I.E. Orsmby, R.J. Diebold, M.J. Eis, T. Doetschman and A.B. Kier (1995) Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. Am. J. Pathol. 146 276-288.
16. L.F. Bonewald (1999) Regulation and regulatory activities of transforming growth factor beta. Crit. Rev. Eukaryot. Gene Expr. 9 33-44.
17. L.F. Bonewald and S.L. Dallas (1994) Role of active and latent transforming growth factor beta in bone formation. J. Cell. Biochem. 55 350-357.
18. L.F. Bonewald, L. Wakefield, R.O. Oreffo, A. Escobedo, D.R. Twardzik and G.R. Mundy (1991) Latent forms of transforming growth factor-beta (TGF beta) derived from bone cultures: identification of a naturally occurring 100-kDa complex with similarity to recombinant latent TGF beta. Mol. Endocrinol. 5 741-751.
19. L.F. Bonewald, M.B. Kester, Z. Schwartz, L.D. Swain, A. Khare, T.L. Johnson, R.J. Leach and B.D. Boyan (1992) Effects of combining transforming growth factor beta and 1, 25- dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63). J. Biol. Chem. 267 8943-8949.
20. L.F. Bonewald, R.O. Oreffo, C.H. Lee, S. Park-Snyder, D. Twardzik and G.R. Mundy (1997) Effects of retinol on activation of latent transforming growth factor-beta by isolated osteoclasts. Endocrinology 138 657-666.
21. A.J. Borton, J.P. Frederick, M.B. Datto, X.F. Wang and R.S. Weinstein (2001) The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J. Bone Miner. Res. 16 1754-1764.
22. A. Bourdeau, D.J. Dumont and M. Letarte (1999) A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 104 1343-1351.
23. B.D. Boyan, Z. Schwartz, S. Park-Snyder, D.D. Dean, F. Yang, D. Twardzik and L.F. Bonewald (1994) Latent transforming growth factor-beta is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1, 25-(OH)2D3. J. Biol. Chem. 269 28374-28381.
24. P.D. Brown, L.M. Wakefield, A.D. Levinson and M.B. Sporn (1990) Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 3 35-43.
25. C.L. Brunet, P.M. Sharpe and M.W. Ferguson (1995) Inhibition of TGF-beta 3 (but not TGF-beta 1 or TGF-beta 2) activity prevents normal mouse embryonic palate fusion. Int. J. Dev. Biol. 39 345-355.
26. M.B. Buck and C. Knabbe (2006) TGF-beta signaling in breast cancer. Ann. N. Y. Acad. Sci. 1089 119-126.
27. W. Bursch, F. Oberhammer and R. Schulte-Hermann (1992) Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci. 13 245-251.
28. M. Centrella, J. Massague and E. Canalis (1986) Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae. Endocrinology 119 2306-2312.
29. M. Centrella, T.L. McCarthy and E. Canalis (1991) Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol. Cell. Biol. 11 4490-4496.
30. M. Centrella, M.C. Horowitz, J.M. Wozney and T.L. McCarthy (1994) Transforming growth factor-beta gene family members and bone. Endocr. Rev. 15 27-39.
31. M. Centrella, S. Casinghino, J. Kim, T. Pham, V. Rosen, J. Wozney and T.L. McCarthy (1995) Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Mol. Cell. Biol. 15 3273-3281.
32. M. Centrella, C. Ji, S. Casinghino and T.L. McCarthy (1996) Rapid flux in transforming growth factor-beta receptors on bone cells. J. Biol. Chem. 271 18616-18622.
33. D.J. Chang, C. Ji, K.K. Kim, S. Casinghino, T.L. McCarthy and M. Centrella (1998) Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid. J. Biol. Chem. 273 4892-4896.
34. H. Chang, C.W. Brown and M.M. Matzuk (2002) Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev. 23 787-823.
35. S.S. Chaudhry, S.A. Cain, A. Morgan, S.L. Dallas, C.A. Shuttleworth and C.M. Kielty (2007) Fibrillin-1 regulates the bioavailability of TGFbeta1. J. Cell Biol. 176 355-367.
36. S. Cheifetz, T. Bellon, C. Cales, S. Vera, C. Bernabeu, J. Massague and M. Letarte (1992) Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J. Biol. Chem. 267 19027-19030.
37. T.L. Chen and R.L. Bates (1993) Recombinant human transforming growth factor beta 1 modulates bone remodeling in a mineralizing bone organ culture. J. Bone Miner. Res. 8 423-434.
38. W. Chen, K.C. Kirkbride, T. How, C.D. Nelson, J. Mo, J.P. Frederick, X.F. Wang, R.J. Lefkowitz and G.C. Blobe (2003) Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and downregulation of its signaling. Science 301 1394-1397.
39. D. Chen, M. Zhao and G.R. Mundy (2004) Bone morphogenetic proteins. Growth Factors 22 233-241.
40. Y. Chen, T. Ali, V. Todorovic, J.M. O'Leary, A. Kristina Downing and D.B. Rifkin (2005) Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes. J. Mol. Biol. 345 175-186.
41. S.E. Crawford, V. Stellmach, J.E. Murphy-Ullrich, S.M. Ribeiro, J. Lawler, R.O. Hynes, G.P. Boivin and N. Bouck (1998) Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93 1159-1170.
42. Q. Cui, S.K. Lim, B. Zhao and F.M. Hoffmann (2005) Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP. Oncogene 24 3864-3874.
43. B. Dabovic, Y. Chen, C. Colarossi, H. Obata, L. Zambuto, M.A. Perle and D.B. Rifkin (2002) Bone abnormalities in latent TGF-β binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-β bioavailability. J. Cell Biol. 156 227-232.
44. B. Dabovic, R. Levasseur, L. Zambuto, Y. Chen, G. Karsenty and D.B. Rifkin (2005) Osteopetrosis-like phenotype in latent TGF-beta binding protein 3 deficient mice. Bone 37 25-31.
45. J.L. Dai, M. Schutte, R.K. Bansal, R.E. Wilentz, A.Y. Sugar and S.E. Kern (1999) Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells. Mol. Carcinog. 26 37-43.
46. S.L. Dallas, S. Park-Snyder, K. Miyazono, D. Twardzik, G.R. Mundy and L.F. Bonewald (1994) Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines, Production of a latent complex lacking the latent TGF beta-binding protein. J. Biol. Chem. 269 6815-6821.
47. S.L. Dallas, K. Miyazono, T.M. Skerry, G.R. Mundy and L.F. Bonewald (1995) Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J. Cell Biol. 131 539-549.
48. S.L. Dallas, D.R. Keene, S.P. Bruder, J. Saharinen, L.Y. Sakai, G.R. Mundy and L.F. Bonewald (2000) Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo. J. Bone Miner. Res. 15 68-81.
49. S.L. Dallas, J.L. Rosser, G.R. Mundy and L.F. Bonewald (2002) Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J. Biol. Chem. 277 21352-21360.
50. S.L. Dallas, S. Zhao, S.D. Cramer, Z. Chen, D.M. Peehl and L.F. Bonewald (2005) Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen. J. Cell Physiol. 202 361-370.
51. S. Daopin, K.A. Piez, Y. Ogawa and D.R. Davies (1992) Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. Science 257 369-373.
52. M.P. de Caestecker, E. Piek and A.B. Roberts (2000) Role of transforming growth factor-beta signaling in cancer. J. Natl. Cancer Inst. 92 1388-1402.
53. D. Dean, M.S. Wolfe, Y. Ahmad, A. Totonchi, J.E. Chen, J.P. Fisher, M.N. Cooke, C.M. Rimnac, D.P. Lennon, A.I. Caplan, N.S. Topham and A.G. Mikos (2005) Effect of transforming growth factor beta 2 on marrow-infused foam poly(propylene fumarate) tissue-engineered constructs for the repair of critical-size cranial defects in rabbits. Tissue Eng 11 923-939.
54. R. Derynck and Y.E. Zhang (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 577-584.
55. R.J. Diebold, M.J. Eis, M. Yin, I. Ormsby, G.P. Boivin, B.J. Darrow, J.E. Saffitz and T. Doetschman (1995) Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. USA, 92 12215-12219.
56. S.C. Dieudonne, P. Foo, E.J. van Zoelen and E.H. Burger (1991) Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures. J. Bone Miner. Res. 6 479-487.
57. M. Dudas, A. Nagy, N.J. Laping, A. Moustakas and V. Kaartinen (2004) TGF-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway. Dev. Biol. 266 96-108.
58. O. Eickelberg, M. Centrella, M. Reiss, M. Kashgarian and R.G. Wells (2002) Betaglycan inhibits TGF-beta signaling by preventing type I- type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function. J. Biol. Chem. 277 823-829.
59. M.E. Engel, M.A. McDonnell, B.K. Law and H.L. Moses (1999) Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J. Biol. Chem. 274 37413-37420.
60. A. Erlebacher and R. Derynck (1996) Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J. Cell Biol. 132 195-210.
61. X.H. Feng and R. Derynck (2005) Specificity and versatility in TGF- signaling through Smads. Annu. Rev. Cell Dev. Biol.
62. M.W. Ferguson and S. O'Kane (2004) Scar-free healing: From embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359 839-850.
63. E. Filvaroff, A. Erlebacher, J. Ye, S.E. Gitelman, J. Lotz, M. Heillman and R. Derynck (1999) Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development 126 4267-4279.
64. R.D. Finkelman, T.A. Linkhart, S. Mohan, K.H. Lau, D.J. Baylink and N.H. Bell (1991) Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: Possible mechanism for impaired osteoinduction. Proc. Natl. Acad. Sci. USA, 88 3657-3660.
65. R.D. Finkelman, N.H. Bell, D.D. Strong, L.M. Demers and D.J. Baylink (1992) Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: Implications for estrogen deficiency-associated bone loss. Proc. Natl. Acad. Sci. USA. 89 1219012193
66. R. Flaumenhaft, M. Abe, Y. Sato, K. Miyazono, J. Harpel, C.H. Heldin and D.B. Rifkin (1993) Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J. Cell Biol. 120 995-1002.
67. L. Fontana, Y. Chen, P. Prijatelj, T. Sakai, R. Fassler, L.Y. Sakai and D.B. Rifkin (2005) Fibronectin is required for integrin alphavbeta6- mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J. 19 1798-1808.
68. S.W. Fox and A.C. Lovibond (2005) Current insights into the role of transforming growth factor-beta in bone resorption. Mol. Cell. Endocrinol. 243 19-26.
69. O. Fromigue, D. Modrowski and P.J. Marie (2004) Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor beta. Curr. Pharm. Des. 10 2593-2603.
70. D. Gazit, Y. Zilberman, G. Turgeman, S. Zhou and A. Kahn (1999) Recombinant TGF-beta1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice. J. Cell. Biochem. 73 379-389.
71. J. Gebken, A. Feydt, J. Brinckmann, H. Notbohm, P.K. Muller and B. Batge (1999) Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors. J. Endocrinol. 161 503-510.
72. A.G. Geiser, Q.Q. Zeng, M. Sato, L.M. Helvering, T. Hirano and C.H. Turner (1998) Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. Bone 23 87-93.
73. L.E. Gentry and B.W. Nash (1990) The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry 29 6851-6857.
74. P.E. Gleizes, R.C. Beavis, R. Mazzieri, B. Shen and D.B. Rifkin (1996) Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-beta binding protein-1 that mediates bonding to the latent transforming growth factor-beta1. J. Biol. Chem. 271 29891-29896.
75. E. Grimaud, D. Heymann and F. Redini (2002) Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev. 13 241-257.
76. T.A. Guise, W.M. Kozlow, A. Heras-Herzig, S.S. Padalecki, J.J. Yin and J.M. Chirgwin (2005) Molecular mechanisms of breast cancer metastases to bone. Clin. Breast Cancer, 5(Suppl), S46-s53.
77. S.E. Harris, L.F. Bonewald, M.A. Harris, M. Sabatini, S. Dallas, J.Q. Feng, N. Ghosh-Choudhury, J. Wozney and G.R. Mundy (1994) Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J. Bone Miner. Res. 9 855-863.
78. G. Hattersley and T.J. Chambers (1991) Effects of transforming growth factor beta 1 on the regulation of osteoclastic development and function. J. Bone Miner. Res. 6 165-172.
79. C.H. Heldin, K. Miyazono and P. ten Dijke (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390 465-471.
80. J. Hellemans, O. Preobrazhenska, A. Willaert, P. Debeer, P.C. Verdonk, T. Costa, K. Janssens, B. Menten, N. Van Roy, S.J. Vermeulen, R. Savarirayan, W. Van Hul, F. Vanhoenacker, D. Huylebroeck, A. De Paepe, J.M. Naeyaert, J. Vandesompele, F. Speleman, K. Verschueren, P.J. Coucke and G.R. Mortier (2004) Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat. Genet. 36 1213-1218.
81. A.P. Hinck, S.J. Archer, S.W. Qian, A.B. Roberts, M.B. Sporn, J.A. Weatherbee, M.L. Tsang, R. Lucas, B.L. Zhang, J. Wenker and D.A. Torchia (1996) Transforming growth factor beta 1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2. Biochemistry 35 8517-8534.
82. J.M. Hock, E. Canalis and M. Centrella (1990) Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 126 421-426.
83. A. Horner, P. Kemp, C. Summers, S. Bord, N.J. Bishop, A.W. Kelsall, N. Coleman and J.E. Compston (1998) Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone 23 95-102.
84. P.P. Hu, M.B. Datto and X.F. Wang (1998) Molecular mechanisms of transforming growth factor-beta signaling. Endocr. Rev. 19 349-363.
85. F.J. Hughes, J.E. Aubin and J.N. Heersche (1992) Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor beta. Bone Miner. 19 63-74.
86. D.E. Hughes, A. Dai, J.C. Tiffee, H.H. Li, G.R. Mundy and B.F. Boyce (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat. Med. 2 1132-1136.
87. M. Hyytiainen, C. Penttinen and J. Keski-Oja (2004) Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit. Rev. Clin. Lab. Sci. 41 233-264.
88. Z. Isogai, R.N. Ono, S. Ushiro, D.R. Keene, Y. Chen, R. Mazzieri, N.L. Charbonneau, D.P. Reinhardt, D.B. Rifkin and L.Y. Sakai (2003) Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J. Biol. Chem. 278 2750-2757.
89. Y. Ito and K. Miyazono (2003) RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr. Opin. Genet. Dev. 13 43-47.
90. S. Itoh, M. Thorikay, M. Kowanetz, A. Moustakas, F. Itoh, C.H. Heldin and P. ten Dijke (2003) Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J. Biol. Chem. 278 3751-3761.
91. S.B. Jakowlew (2006) Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev. 25 435-457.
92. K. Janssens, P. ten Dijke, S.H. Ralston, C. Bergmann and W. Van Hul (2003) Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J. Biol. Chem. 278 7718-7724.
93. K. Janssens, P. ten Dijke, S. Janssens and W. Van Hul (2005) Transforming growth factor-beta1 to the bone. Endocr. Rev. 26 743-774.
94. K. Janssens, F. Vanhoenacker, M. Bonduelle, L. Verbruggen, L. Van Maldergem, S. Ralston, N. Guanabens, N. Migone, S. Wientroub, M.T. Divizia, C. Bergmann, C. Bennett, S. Simsek, S. Melancon, T. Cundy and W. Van Hul (2006) Camurati-Engelmann disease: Review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J. Med. Genet. 43 1-11.
95. C. Ji, S. Casinghino, D.J. Chang, Y. Chen, A. Javed, Y. Ito, S.W. Hiebert, J.B. Lian, G.S. Stein, T.L. McCarthy and M. Centrella (1998) CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J. Cell. Biochem. 69 353-363.
96. H. Jian, X. Shen, I. Liu, M. Semenov, X. He and X.F. Wang (2006) Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev. 20 666-674.
97. Y.H. Jin, E.J. Jeon, Q.L. Li, Y.H. Lee, J.K. Choi, W.J. Kim, K.Y. Lee and S.C. Bae (2004) Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. J. Biol. Chem. 279 29409-29417.
98. M.E. Joyce, A.B. Roberts, M.B. Sporn and M.E. Bolander (1990) Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 110 2195-2207.
99. D.P. Judge and H.C. Dietz (2005) Marfan's syndrome. Lancet 366 1965-1976.
100. V. Kaartinen, J.W. Voncken, C. Shuler, D. Warburton, D. Bu, N. Heisterkamp and J. Groffen (1995) Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11 415-421.
101. D.N. Kalu, E. Salerno, Y. Higami, C.C. Liu, F. Ferraro, M.A. Salih and B.H. Arjmandi (1993) In vivo effects of transforming growth factor-beta 2 in ovariectomized rats. Bone Miner. 22 209-220.
102. S. Kamakura, Y. Sasano, S. Nakajo, T. Shimizu, O. Suzuki, F. Katou, M. Kagayama and K. Motegi (2001) Implantation of octacalcium phosphate combined with transforming growth factor-beta1 enhances bone repair as well as resorption of the implant in rat skull defects. J. Biomed. Mater. Res. 57 175-182.
103. T. Kaneda, T. Nojima, M. Nakagawa, A. Ogasawara, H. Kaneko, T. Sato, H. Mano, M. Kumegawa and Y. Hakeda (2000) Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. J. Immunol. 165 4254-4263.
104. J.S. Kang, T. Alliston, R. Delston and R. Derynck (2005) Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 24 2543-2555.
105. M.A. Karsdal, M.S. Fjording, N.T. Foged, J.M. Delaisse and A. Lochter (2001) Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase- and matrix metalloproteinase-dependent pathway. J. Biol. Chem. 276 39350-39358.
106. M.A. Karsdal, L. Larsen, M.T. Engsig, H. Lou, M. Ferreras, A. Lochter, J.M. Delaisse and N.T. Foged (2002) Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J. Biol. Chem. 277 44061-44067.
107. M.A. Karsdal, P. Hjorth, K. Henriksen, T. Kirkegaard, K.L. Nielsen, H. Lou, J.M. Delaisse and N.T. Foged (2003) Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. J. Biol. Chem. 278 44975-44987.
108. M. Karst, G. Gorny, R.J. Galvin and M.J. Oursler (2004) Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J. Cell Physiol. 200 99-106.
109. T. Katagiri, A. Yamaguchi, M. Komaki, E. Abe, N. Takahashi, T. Ikeda, V. Rosen, J.M. Wozney, A. Fujisawa-Sehara and T. Suda (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127 1755-1766.
110. D.J. Kibblewhite, A.G. Bruce, D.M. Strong, S.M. Ott, A.F. Purchio and W.F. Larrabee Jr. (1993) Transforming growth factor-beta accelerates osteoinduction in a craniofacial onlay model. Growth Factors 9 185-193.
111. S.J. Kim, A. Glick, M.B. Sporn and A.B. Roberts (1989) Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J. Biol. Chem. 264 402-408.
112. L. Kohlmeier, C. Gasner, L.K. Bachrach and R. Marcus (1995) The bone mineral status of patients with Marfan syndrome. Bone Miner. J. Bone Miner. Res. 10 1550-1555.
113. K. Koli, F. Wempe, A. Sterner-Kock, A. Kantola, M. Komor, W.K. Hofmann, H. von Melchner and J. Keski-Oja (2004) Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung. J. Cell Biol. 167 123-133.
114. Y. Komatsu, H. Shibuya, N. Takeda, J. Ninomiya-Tsuji, T. Yasui, K. Miyado, T. Sekimoto, N. Ueno, K. Matsumoto and G. Yamada (2002) Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech. Dev. 119 239-249.
115. A.B. Kulkarni and S. Karlsson (1993) Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143 3-9.
116. R. Lafyatis, N.L. Thompson, E.F. Remmers, K.C. Flanders, N.S. Roche, S.J. Kim, J.P. Case, M.B. Sporn, A.B. Roberts and R.L. Wilder (1989) Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J. Immunol. 143 1142-1148.
117. R. Lafyatis, R. Lechleider, S.J. Kim, S. Jakowlew, A.B. Roberts and M.B. Sporn (1990) Structural and functional characterization of the transforming growth factor beta 3 promoter. A cAMP-responsive element regulates basal and induced transcription. J. Biol. Chem. 265 19128-19136.
118. C.F. Lai and S.L. Cheng (2002) Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J. Biol. Chem. 277 15514-15522.
119. D.A. Lawrence, R. Pircher and P. Jullien (1985) Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem, Biophys. Res. Commun. 133 1026-1034.
120. A. Leask (2007) TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc. Res. 74 207-212.
121. U.H. Lerner (1996) Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway. Bone Miner. J. Bone Miner. Res. 11 1628-1639.
122. J.J. Letterio, A.G. Geiser, A.B. Kulkarni, N.S. Roche, M.B. Sporn and A.B. Roberts (1994) Maternal rescue of transforming growth factor-beta 1 null mice. Science 264 1936-1938.
123. M. Lin, S. Overgaard, H. Glerup, K. Soballe and C. Bunger (2001) Transforming growth factor-beta1 adsorbed to tricalcium phosphate coated implants increases peri-implant bone remodeling. Biomaterials 22 189-193.
124. F. Lin, J.M. Morrison, W. Wu and H.J. Worman (2005) MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-beta signaling. Hum. Mol. Genet. 14 437-445.
125. S.J. Lin, T.F. Lerch, R.W. Cook, T.S. Jardetzky and T.K. Woodruff (2006) The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding. Reproduction 132 179-190.
126. B.L. Loeys, J. Chen, E.R. Neptune, D.P. Judge, M. Podowski, T. Holm, J. Meyers, C.C. Leitch, N. Katsanis, N. Sharifi, F.L. Xu, L.A. Myers, P.J. Spevak, D.E. Cameron, J. De Backer, J. Hellemans, Y. Chen, E.C. Davis, C.L. Webb, W. Kress, P. Coucke, D.B. Rifkin, A.M. De Paepe and H.C. Dietz (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37 275-281.
127. F. Lopez-Casillas, J.L. Wrana and J. Massague (1993) Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73 1435-1444.
128. M. Lotz, J. Kekow and D.A. Carson (1990) Transforming growth factor-beta and cellular immune responses in synovial fluids. J. Immunol. 144 4189-4194.
129. P.A. Lucas (1989) Chemotactic response of osteoblast-like cells to transforming growth factor beta. Bone 10 459-463.
130. R.M. Lyons, J. Keski-Oja and H.L. Moses (1988) Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J. Cell Biol. 106 1659-1665.
131. R.M. Lyons, L.E. Gentry, A.F. Purchio and H.L. Moses (1990) Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J. Cell Biol. 110 1361-1367.
132. M. Machwate, E. Zerath, X. Holy, M. Hott, D. Godet, A. Lomri and P.J. Marie (1995) Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia induced by unloading in rats. J, Clin. Invest. 96 1245-1253.
133. E.J. Mackie and U. Trechsel (1990) Stimulation of bone formation in vivo by transforming growth factor-beta: Remodeling of woven bone and lack of inhibition by indomethacin. Bone 11 295-300.
134. S. Maeda, D.D. Dean, R. Gomez, Z. Schwartz and B.D. Boyan (2002) The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Calcif. Tissue Int. 70 54-65.
135. U. Malipiero, M. Holler, U. Werner and A. Fontana (1990) Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor/transforming growth factor (TGF)-beta 2 gene reveals striking differences to the TGF-beta 1 and -beta 3 genes. Biochem, Biophys. Res. Commun. 171 1145-1151.
136. C. Marcelli, A.J. Yates and G.R. Mundy (1990) In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. Bone Miner.J. Bone Miner. Res. 5 1087-1096.
137. F. Marra, L.F. Bonewald, S. Park-Snyder, I.S. Park, K.A. Woodruff and H.E. Abboud (1996) Characterization and regulation of the latent transforming growth factor-beta complex secreted by vascular pericytes. J. Cell Physiol. 166 537-546.
138. T.L. McCarthy, W.Z. Chang, Y. Liu and M. Centrella (2003) Runx2 integrates estrogen activity in osteoblasts. J. Biol. Chem. 278 43121-43129.
139. K. Miyazono, A. Olofsson, P. Colosetti and C.H. Heldin (1991) A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J. 10 1091-1101.
140. T. Mizuguchi and N. Matsumoto (2007) Recent progress in genetics of Marfan syndrome and Marfan-associated disorders. J. Hum. Genet. 52 1-12.
141. D. Mu, S. Cambier, L. Fjellbirkeland, J.L. Baron, J.S. Munger, H. Kawakatsu, D. Sheppard, V.C. Broaddus and S.L. Nishimura (2002) The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J. Cell Biol. 157 493-507.
142. K.M. Mulder (2000) Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev. 11 23-35.
143. J.S. Munger, X. Huang, H. Kawakatsu, M.J. Griffiths, S.L. Dalton, J. Wu, J.F. Pittet, N. Kaminski, C. Garat, M.A. Matthay, D.B. Rifkin and D. Sheppard (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96 319-328.
144. J.E. Murphy-Ullrich and M. Poczatek (2000) Activation of latent TGF-beta by thrombospondin-1: Mechanisms and physiology. Cytokine Growth Factor Rev. 11 59-69.
145. E.R. Neptune, P.A. Frischmeyer, D.E. Arking, L. Myers, T.E. Bunton, B. Gayraud, F. Ramirez, L.Y. Sakai and H.C. Dietz (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33 407-411.
146. M. Noda and J.J. Camilliere (1989) In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124 2991-2994.
147. M. Noda and G.A. Rodan (1986) Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. Biochem, Biophys. Res. Commun. 140 56-65.
148. M. Noda and G.A. Rodan (1989) Type beta transforming growth factor regulates expression of genes encoding bone matrix proteins. Connect. Tissue Res. 21 71-75.
149. M. Nomura and E. Li (1998) Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393 786-790.
150. A. Olofsson, H. Ichijo, A. Moren, P. ten Dijke, K. Miyazono and C.H. Heldin (1995) Efficient association of an amino-terminally extended form of human latent transforming growth factor-beta binding protein with the extracellular matrix. J. Biol. Chem. 270 31294-31297.
151. L.A. Opperman, A. Chhabra, R.W. Cho and R.C. Ogle (1999) Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro. J. Craniofac. Genet. Dev. Biol. 19 164-173.
152. R.O. Oreffo, G.R. Mundy, S.M. Seyedin and L.F. Bonewald (1989) Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochem, Biophys. Res. Commun. 158 817-823.
153. M.J. Oursler (1994) Osteoclast synthesis and secretion and activation of latent transforming growth factor beta. Bone Miner.J. Bone Miner. Res. 9 443-452.
154. M.J. Oursler, B.L. Riggs and T.C. Spelsberg (1993) Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology 133 2187-2196.
155. S. Palcy and D. Goltzman (1999) Protein kinase signalling pathways involved in the up-regulation of the rat alpha1(I) collagen gene by transforming growth factor beta1 and bone morphogenetic protein 2 in osteoblastic cells. Biochem. J. 343(Pt 1), 21-27.
156. R. Pankov, E. Cukierman, B.Z. Katz, K. Matsumoto, D.C. Lin, S. Lin, C. Hahn and K.M. Yamada (2000) Integrin dynamics and matrix assembly: Tensin-dependent translocation of alpha(5)beta(1) integrins promotes early fibronectin fibrillogenesis. J. Cell Biol. 148 1075-1090.
157. H. Pannu, V.T. Fadulu, J. Chang, A. Lafont, S.N. Hasham, E. Sparks, P.F. Giampietro, C. Zaleski, A.L. Estrera, H.J. Safi, S. Shete, M.C. Willing, C.S. Raman and D.M. Milewicz (2005) Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112 513-520.
158. K. Pardali and A. Moustakas (2007) Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta, 1775 21-62.
159. M. Pessah, C. Prunier, J. Marais, N. Ferrand, A. Mazars, F. Lallemand, J.M. Gauthier and A. Atfi (2001) c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity. Proc. Natl. Acad. Sci. USA 98 6198-6203.
160. J. Pfeilschifter and G.R. Mundy (1987) Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc. Natl. Acad. Sci. USA, 84 2024-2028.
161. J. Pfeilschifter, S.M. Seyedin and G.R. Mundy (1988) Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. J. Clin. Invest. 82 680-685.
162. J. Pfeilschifter, O. Wolf, A. Naumann, H.W. Minne, G.R. Mundy and R. Ziegler (1990) Chemotactic response of osteoblastlike cells to transforming growth factor beta. J. Bone Miner. Res. 5 825-830.
163. J. Pfeilschifter, F. Laukhuf, B. Muller-Beckmann, W.F. Blum, T. Pfister and R. Ziegler (1995) Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J, Clin. Invest. 96 767-774.
164. C.C. Pilbeam, H. Kawaguchi, Y. Hakeda, O. Voznesensky, C.B. Alander and L.G. Raisz (1993) Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3E1 cells. J. Biol. Chem. 268 25643-25649.
165. M.F. Pilkington, S.M. Sims and S.J. Dixon (2001) Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: Potential role in osteoclast recruitment. Bone Miner.J. Bone Miner. Res. 16 1237-1247.
166. R. Pircher, P. Jullien and D.A. Lawrence (1986) Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem, Biophys. Res. Commun. 136 30-37.
167. A.E. Postlethwaite and J.M. Seyer (1995) Identification of a chemotactic epitope in human transforming growth factor-beta 1 spanning amino acid residues 368–374. J. Cell Physiol. 164 587-592.
168. G. Proetzel, S.A. Pawlowski, M.V.V. Wiles, M. Yin, G.P. Boivin, P.N. Howles, J. Ding, M.W. Ferguson and T. Doetschman (1995) Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 11 409-414.
169. F. Redini, A. Mauviel, S. Pronost, G. Loyau and J.P. Pujol (1993) Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum. 36 44-50.
170. D.B. Rifkin (2005) Latent transforming growth factor-beta (TGF-beta) binding proteins: Orchestrators of TGF-beta availability. J. Biol. Chem. 280 7409-7412.
171. A.B. Roberts (1998) Molecular and cell biology of TGF-beta. Miner. Electrolyte Metab. 24 111-119.
172. P.G. Robey, M.F. Young, K.C. Flanders, N.S. Roche, P. Kondaiah, A.H. Reddi, J.D. Termine, M.B. Sporn and A.B. Roberts (1987) Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J. Cell Biol. 105 457-463.
173. D. Rosen, S.C. Miller, E. DeLeon, A.Y. Thompson, H. Bentz, M. Mathews and S. Adams (1994) Systemic administration of recombinant transforming growth factor beta 2 (rTGF-beta 2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 15 355-359.
174. J. Saharinen and J. Keski-Oja (2000) Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. Mol. Biol. Cell. 11 2691-2704.
175. J. Saharinen, J. Taipale and J. Keski-Oja (1996) Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1. EMBO J. 15 245-253.
176. T. Saito, A. Kinoshita, K. Yoshiura, Y. Makita, K. Wakui, K. Honke, N. Niikawa and N. Taniguchi (2001) Domain-specific mutations of a transforming growth factor (TGF)-beta 1 latency-associated peptide cause Camurati-Engelmann disease because of the formation of a constitutively active form of TGF-beta 1. J. Biol. Chem. 276 11469-11472.
177. T. Sakou, T. Onishi, T. Yamamoto, T. Nagamine, T. Sampath and P. Ten Dijke (1999) Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification. J. Bone Miner. Res. 14 1145-1152.
178. L.P. Sanford, I. Ormsby, A.C. Gittenberger-de Groot, H. Sariola, R. Friedman, G.P. Boivin, E.L. Cardell and T. Doetschman (1997) TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124 2659-2670.
179. Y. Sato and D.B. Rifkin (1989) Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J. Cell Biol. 109 309-315.
180. A. Scharstuhl, H.L. Glansbeek, H.M. van Beuningen, E.L. Vitters, P.M. van der Kraan and W.B. van den Berg (2002) Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J. Immunol. 169 507-514.
181. S. Schultz-Cherry, H. Chen, D.F. Mosher, T.M. Misenheimer, H.C. Krutzsch, D.D. Roberts and J.E. Murphy-Ullrich (1995) Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J. Biol. Chem. 270 7304-7310.
182. P.R. Segarini, D.M. Rosen and S.M. Seyedin (1989) Binding of transforming growth factor-beta to cell surface proteins varies with cell type. Mol. Endocrinol. 3 261-272.
183. N. Selvamurugan, S. Kwok, T. Alliston, M. Reiss and N.C. Partridge (2004) Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2. J. Biol. Chem. 279 19327-19334.
184. D. Sheppard (2001) Integrin-mediated activation of transforming growth factor-beta(1) in pulmonary fibrosis. Chest 120 49S-s53S.
185. D. Sheppard (2005) Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev. 24 395-402.
186. D. Sheppard (2006) Transforming growth factor beta: A central modulator of pulmonary and airway inflammation and fibrosis. Proc. Am. Thorac. Soc. 3 413-417.
187. Y. Shi and J. Massague (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 685-700.
188. M.M. Shull, I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata and T. Doetschman (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359 693-699.
189. I.A. Silver, R.J. Murrills and D.J. Etherington (1988) Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell Res. 175 266-276.
190. C. Sirard, J.L. de la Pompa, A. Elia, A. Itie, C. Mirtsos, A. Cheung, S. Hahn, A. Wakeham, L. Schwartz, S.E. Kern, J. Rossant and T.W. Mak (1998) The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12 107-119.
191. H. Sowa, H. Kaji, T. Yamaguchi, T. Sugimoto and K. Chihara (2002) Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J. Biol. Chem. 277 36024-36031.
192. H. Sowa, H. Kaji, L. Canaff, G.N. Hendy, T. Tsukamoto, T. Yamaguchi, K. Miyazono, T. Sugimoto and K. Chihara (2003) Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. J. Biol. Chem. 278 21058-21069.
193. S. Spinella-Jaegle, S. Roman-Roman, C. Faucheu, F.W. Dunn, S. Kawai, S. Gallea, V. Stiot, A.M. Blanchet, B. Courtois, R. Baron and G. Rawadi (2001) Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 29 323-330.
194. S. Srouji, A. Rachmiel, I. Blumenfeld and E. Livne (2005) Mandibular defect repair by TGF-beta and IGF-1 released from a biodegradable osteoconductive hydrogel. J. Craniomaxillofac. Surg. 33 79-84.
195. K.L. Stenvers, M.L. Tursky, K.W. Harder, N. Kountouri, S. Amatayakul-Chantler, D. Grail, C. Small, R.A. Weinberg, A.M. Sizeland and H.J. Zhu (2003) Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos. Mol. Cell. Biol. 23 4371-4385.
196. A. Sterner-Kock, I.S. Thorey, K. Koli, F. Wempe, J. Otte, T. Bangsow, K. Kuhlmeier, T. Kirchner, S. Jin, J. Keski-Oja and H. von Melchner (2002) Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev. 16 2264-2273.
197. D.R. Sumner, T.M. Turner, R.M. Urban, A.S. Virdi and N. Inoue (2006) Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model. J. Bone Joint Surg. Am. 88 806-817.
198. Z. Szekanecz, G.K. Haines, L.A. Harlow, M.R. Shah, T.W. Fong, R. Fu, S.J. Lin, G. Rayan and A.E. Koch (1995) Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: Possible interactions in the pathogenesis of the disease. Clin. Immunol. Immunopathol. 76 187-194.
199. J. Taipale, K. Miyazono, C.H. Heldin and J. Keski-Oja (1994) Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J. Cell Biol. 124 171-181.
200. J. Taipale, J. Lohi, J. Saarinen, P.T. Kovanen and J. Keski-Oja (1995) Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270 4689-4696.
201. N. Takahashi, K. Rieneck, P.M. van der Kraan, H.M. van Beuningen, E.L. Vitters, K. Bendtzen and W.B. van den Berg (2005) Elucidation of IL-1/TGF-beta interactions in mouse chondrocyte cell line by genome-wide gene expression. Osteoarthritis Cartilage 13 426-438.
202. H. Takai, M. Kanematsu, K. Yano, E. Tsuda, K. Higashio, K. Ikeda, K. Watanabe and Y. Yamada (1998) Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J. Biol. Chem. 273 27091-27096.
203. F. Taketazu, M. Kato, A. Gobl, H. Ichijo, P. ten Dijke, J. Itoh, M. Kyogoku, J. Ronnelid, K. Miyazono, C.H. Heldin and F. Keiko (1994) Enhanced expression of transforming growth factor-beta and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab. Invest. 70 620-630.
204. Y. Takeuchi, K. Nakayama and T. Matsumoto (1996) Differentiation and cell surface expression of transforming growth factor-beta receptors are regulated by interaction with matrix collagen in murine osteoblastic cells. J. Biol. Chem. 271 3938-3944.
205. A.H. Tashjian Jr., E.F. Voelkel, M. Lazzaro, F.R. Singer, A.B. Roberts, R. Derynck, M.E. Winkler and L. Levine (1985) Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc. Natl. Acad. Sci. USA, 82 4535-4538.
206. Y. Taya, S. O'Kane and M.W. Ferguson (1999) Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development 126 3869-3879.
207. P. ten Dijke and C.S. Hill (2004) New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29 265-273.
208. T. Tobimatsu, H. Kaji, H. Sowa, J. Naito, L. Canaff, G.N. Hendy, T. Sugimoto and K. Chihara (2006) Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147 2583-2590.
209. V. Todorovic, V. Jurukovski, Y. Chen, L. Fontana, B. Dabovic and D.B. Rifkin (2005) Latent TGF-beta binding proteins. Int. J. Biochem. Cell Biol. 37 38-41.
210. J.E. Wergedal, T. Matsuyama and D.D. Strong (1992) Differentiation of normal human bone cells by transforming growth factor-beta and 1, 25(OH)2 vitamin D3. Metabolism 41 42-48.
211. K. Yamaguchi, K. Shirakabe, H. Shibuya, K. Irie, I. Oishi, N. Ueno, T. Taniguchi, E. Nishida and K. Matsumoto (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270 2008-2011.
212. Y. Yanagi, M. Suzawa, M. Kawabata, K. Miyazono, J. Yanagisawa and S. Kato (1999) Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J. Biol. Chem. 274 12971-12974.
213. J. Yanagisawa, Y. Yanagi, Y. Masuhiro, M. Suzawa, M. Watanabe, K. Kashiwagi, T. Toriyabe, M. Kawabata, K. Miyazono and S. Kato (1999) Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283 1317-1321.
214. X. Yang, C. Li, X. Xu and C. Deng (1998) The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc. Natl. Acad. Sci. USA, 95 3667-3672.
215. X. Yang, L. Chen, X. Xu, C. Li, C. Huang and C.X. Deng (2001) TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol. 153 35-46.
216. Y.C. Yang, E. Piek, J. Zavadil, D. Liang, D. Xie, J. Heyer, P. Pavlidis, R. Kucherlapati, A.B. Roberts and E.P. Bottinger (2003) Hierarchical model of gene regulation by transforming growth factor beta. Proc. Natl. Acad. Sci. USA, 100 10269-10274.
217. J.A. Yee, L. Yan, J.C. Dominguez, E.H. Allan and T.J. Martin (1993) Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells. J. Cell Physiol. 157 528-534.
218. W. Yin, E. Smiley, J. Germiller, R.P. Mecham, J.B. Florer, R.J. Wenstrup and J. Bonadio (1995) Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3). J. Biol. Chem. 270 10147-10160.
219. G.D. Young and J.E. Murphy-Ullrich (2004) Molecular interactions that confer latency to transforming growth factor-beta. J. Biol. Chem. 279 38032-38039.
220. Q. Yu and I. Stamenkovic (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14 163-176.
221. L. Yu, M.C. Hebert and Y.E. Zhang (2002) TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 21 3749-3759.
222. S.K. Zaidi, A.J. Sullivan, A.J. van Wijnen, J.L. Stein, G.S. Stein and J.B. Lian (2002) Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc. Natl. Acad. Sci. USA, 99 8048-8053.
223. Y. Zhang and R. Derynck (2000) Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members. J. Biol. Chem. 275 16979-16985.
224. Y.W. Zhang, N. Yasui, K. Ito, G. Huang, M. Fujii, J. Hanai, H. Nogami, T. Ochi, K. Miyazono and Y. Ito (2000) A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. USA, 97 10549-10554.
225. J. Zhang, X. Tan, W. Li, Y. Wang, J. Wang, X. Cheng and X. Yang (2005) Smad4 is required for the normal organization of the cartilage growth plate. Dev. Biol. 284 311-322.